ANTIGENICS INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 10th, 2008 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of April 8, 2008, by and among Antigenics Inc., a Delaware corporation (the “Company”) and the investors signatory hereto and identified for convenience on Schedule I attached hereto (each, a “Purchaser”, and collectively, the “Purchasers”).
ANTIGENICS INC WARRANTSecurities Agreement • April 10th, 2008 • Antigenics Inc /De/ • Biological products, (no disgnostic substances)
Antigenics Inc., a Delaware corporation (the “Company”), hereby certifies that, for value received, or its registered assigns (including permitted transferees, the “Holder”), as registered owner of this warrant (the “Warrant”), is entitled to purchase from the Company up to a total of shares (as adjusted from time to time as provided in Section 9) of Common Stock (as defined below), at an exercise price equal to $3.75 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time and from time to time from and after October10, 2008 (the “Initial Exercise Date”) to and including April 9, 2013 (the “Expiration Date”), and subject to the following terms and conditions.
